Ads
related to: treatment regimen for multiple myeloma cancer life expectancy chart- Transform Myeloma
Multiple Myeloma Information
and Resources for HCPs
- Importance of MRD-
The Importance of Achieving MRD
Negativity for Impacting Outcomes
- Frontline MM Landscape
Evolving 1st-Line MM Care
Towards Improved Outcomes
- MRD Negativity FAQs
Frequently Asked Questions
About Minimal Residual Disease
- Transform Myeloma
Search results
Results from the WOW.Com Content Network
The term "induction regimen" refers to a chemotherapy regimen used for the initial treatment of a disease. A "maintenance regimen" refers to the ongoing use of chemotherapy to reduce the chances of a cancer recurring or to prevent an existing cancer from continuing to grow. [2]
DT-PACE refers to a chemotherapy regimen for multiple myeloma consisting of Dexamethasone, Thalidomide, Cisplatin or Platinol, Adriamycin or doxorubicin, Cyclophosphamide, and Etoposide. [ 1 ] References
Multiple myeloma is the second-most prevalent blood cancer (10%) after non-Hodgkin's lymphoma. [154] It represents about 1.8% of all new cancers and 2.1% of all cancer deaths. [7] Multiple myeloma affects slightly more men than women.
Pages in category "Chemotherapy regimens used in multiple myeloma" The following 2 pages are in this category, out of 2 total.
Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. [4] This includes multiple myeloma in those who have and have not previously received treatment. [3] It is generally used together with other medications. [3] It is given by injection. [4]
Tyrosine kinase inhibitors like imatinib have improved the prognosis of CML patients to near-normal life expectancy. [14] Recently, a JAK2 inhibitor, namely ruxolitinib, has been approved for use in primary myelofibrosis. [15] Trials of these inhibitors are in progress for the treatment of the other myeloproliferative neoplasms.
Ads
related to: treatment regimen for multiple myeloma cancer life expectancy chart